Mondal S, Heidelberger C
Cancer Res. 1980 Feb;40(2):334-8.
C3H/10T 1/2 cells were induced to differentiate into muscle cells by treatment with 5-azacytidine, and the effects of tumor promoters, nonpromoters, and inhibitors of tumor promotion on this induced differentiation were investigated. Cell morphology was dramatically changed within 30 min after treatment with phorbol ester-related tumor promoters and mezereine but not with other tumor promoters. There was a good correlation between the tumor-promoting activity of the compounds and their inhibitory action on differentiation except in case of phenobarbital; this promoter of liver carcinogenesis did not inhibit differentiation. Inhibitors of tumor promotion, dexamethasone, fluocinolone acetonide, retinoic acid, and antipain, also inhibited the 5-azacytidine-induced differentiation. When the cells were treated after induction of differentiation with 12-O-tetradecanoylphorbol-13-acetate, a potent tumor promoter, and simultaneously with one of those inhibitors of tumor promotion, the inhibitory action of 12-O-tetradecanoylphorbol-13-acetate was not affected. From these facts, it is evident that using a single phenomenon produced by one class of tumor promoter as a criterion for screening environmental tumor promoters is not justifiable.
用5-氮杂胞苷处理C3H/10T 1/2细胞,诱导其分化为肌肉细胞,并研究肿瘤启动剂、非启动剂和肿瘤促进抑制剂对这种诱导分化的影响。在用佛波酯相关肿瘤启动剂和狼毒素处理后30分钟内,细胞形态发生了显著变化,但其他肿瘤启动剂处理则无此现象。除苯巴比妥外,化合物的肿瘤促进活性与其对分化的抑制作用之间存在良好的相关性;这种肝癌发生启动剂并不抑制分化。肿瘤促进抑制剂地塞米松、醋酸氟轻松、视黄酸和抑肽酶也抑制5-氮杂胞苷诱导的分化。当细胞在用强效肿瘤启动剂12-O-十四酰佛波醇-13-乙酸酯诱导分化后进行处理,并同时使用这些肿瘤促进抑制剂之一时,12-O-十四酰佛波醇-13-乙酸酯的抑制作用不受影响。从这些事实可以明显看出,将一类肿瘤启动剂产生的单一现象作为筛选环境肿瘤启动剂的标准是不合理的。